Theravance Inc (NASDAQ:THRX)

19.64
Delayed Data
As of Mar 04
 +0.08 / +0.41%
Today’s Change
10.58
Today|||52-Week Range
31.80
+38.80%
Year-to-Date
THRX Regular Dividend: THRX will begin trading ex-dividend on 03/10/15 with a $0.25 dividend payable to shareholders of record as of 03/12/15.

Today’s Trading

Previous close19.56
Today’s open19.44
Day’s range19.15 - 19.72
Volume878,554
Average volume (3 months)1,013,970
Market cap$2.3B
Dividend yield5.09%
Data as of 4:00pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+91.22%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Cosmo Pharmaceutical...+9.35+6.24%
PTCTPTC Therapeutics Inc+1.38+1.99%
LCILannett Company Inc+0.01+0.02%
IRWDIronwood Pharmaceuti...-0.03-0.19%
Data as of 4:01pm ET, 03/04/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account